Vimarsana
Biggest News Aggregation in the World

Page 16 - Director John News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director John. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director John Today - Breaking & Trending Today

BankUnited, Inc. (NYSE:BKU) Receives $30.50 Consensus Target Price from Analysts - Vimarsana News

BankUnited, Inc. (NYSE:BKU) Receives $30.50 Consensus Target Price from Analysts

BankUnited, Inc. (NYSE:BKU – Get Free Report) has been given a consensus recommendation of “Reduce” by the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. The average 1 year price objective […]

California seeks to delay $25 health-care minimum wage to ward off budget crisis - Vimarsana News

California seeks to delay $25 health-care minimum wage to ward off budget crisis

(The Center Square) – California Gov. Gavin Newsom is seeking to delay a healthcare worker minimum wage increase that will cost the state $4 billion this year alone as the

RS Crum Inc. Takes Position in Alphabet Inc. (NASDAQ:GOOG) - Vimarsana News

RS Crum Inc. Takes Position in Alphabet Inc. (NASDAQ:GOOG)

RS Crum Inc. acquired a new position in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,458 shares of the information services provider’s stock, valued at approximately $205,000. Several other […]

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts - Vimarsana News

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have been given an average rating of “Moderate Buy” by the seventeen brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 […]

Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Rating of "Moderate Buy" by Analysts - Vimarsana News

Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Rating of "Moderate Buy" by Analysts

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 1-year target price among analysts […]